SFRP4 gene expression has previously been linked to more aggressive prostate cancer; Luo et al. 8 showed increased expression of SFRP4 in tissue samples from prostate cancer patients with pathological stage T3a-b compared with pathological stage T2b. This evidence concerns the gene SFRP4 and prostate cancer.